A collection of 1,308 clinical Mycobacterium tuberculosis isolates from Ontario, Canada, was genotyped by IS6110 restriction fragment length polymorphism (RFLP) and mycobacterial interspersed repetitive-unitvariable-number tandem-repeat (MIRU-VNTR) analysis. RFLP or >12 MIRU-VNTR loci were necessary for resolution of Indo-Oceanic strains. The low clustering rate and high strain diversity indicate that, in Ontario, most tuberculosis results from reactivation of latent infections. Tuberculosis (TB), which is caused by pathogens of the Mycobacterium tuberculosis complex (MTBC), remains a global scourge (19). In Canada, the average incidence rate is 5.0 cases/100,000 people, but the burden of disease varies across the country. In 2007, the four Atlantic provinces accounted for only ϳ1% of TB cases, whereas ϳ42% of new cases occurred in the province of Ontario (11). The Public Health Laboratories (PHL) of the Ontario Agency for Health Protection and Promotion provide diagnostic testing for TB in Ontario. The TB and Mycobacteriology Laboratory at PHL-Toronto is the largest facility of its kind in Canada, processing 50,000 patient samples plus 2,000 referred acid-fast positive cultures, with 600 to 650 new cases of TB detected annually (8, 11). Historically, the PHL has employed IS6110 restriction fragment length polymorphism (RFLP) for genotyping. Despite its utility, IS6110 RFLP is labor-intensive and only performed upon request. The current turnaround time of 21 days also makes the method incompatible with the PHL goal of universal, real-time MTBC genotyping. More recently, mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) typing has been introduced (6, 7, 9, 15). The current PHL strategy relies upon agarose gel electrophoresis for comparison of PCR products. This method is low throughput, and gel-togel variability confounds comparison of samples processed at different times. Here, we describe implementation and validation of an improved MIRU-VNTR strategy and its utility for analysis of a large clinical strain collection.
Tuberculosis (TB), which is caused by pathogens of the Mycobacterium tuberculosis complex (MTBC), remains a global scourge (19) . In Canada, the average incidence rate is 5.0 cases/100,000 people, but the burden of disease varies across the country. In 2007, the four Atlantic provinces accounted for only ϳ1% of TB cases, whereas ϳ42% of new cases occurred in the province of Ontario (11) . The Public Health Laboratories (PHL) of the Ontario Agency for Health Protection and Promotion provide diagnostic testing for TB in Ontario. The TB and Mycobacteriology Laboratory at PHL-Toronto is the largest facility of its kind in Canada, processing 50,000 patient samples plus 2,000 referred acid-fast positive cultures, with 600 to 650 new cases of TB detected annually (8, 11) . Historically, the PHL has employed IS6110 restriction fragment length polymorphism (RFLP) for genotyping. Despite its utility, IS6110 RFLP is labor-intensive and only performed upon request. The current turnaround time of 21 days also makes the method incompatible with the PHL goal of universal, real-time MTBC genotyping. More recently, mycobacterial interspersed repetitive-unit-variable-number tandem-repeat (MIRU-VNTR) typing has been introduced (6, 7, 9, 15) . The current PHL strategy relies upon agarose gel electrophoresis for comparison of PCR products. This method is low throughput, and gel-togel variability confounds comparison of samples processed at different times. Here, we describe implementation and validation of an improved MIRU-VNTR strategy and its utility for analysis of a large clinical strain collection.
The semiautomated MIRU-VNTR strategy was derived from the 12-loci method of Cowan et al. (6, 7) . Briefly, multiplex PCR was performed with dye-labeled primers in 96-well plates. For each reaction, 5 ng of template DNA was combined with 11 l of a master mix (Red Taq; Sigma-Aldrich, Oakville, Canada) containing three primer pairs. PCR conditions were 95°C for 10 min and 34 cycles of 94°C for 30 s, 62°C for 30 s, and 72°C for 60 s, with a final extension at 72°C for 7 min. PCR amplification was confirmed by electrophoresis on 1% Trisborate-EDTA agarose gels. Samples were diluted 1:20 in sequence loading solution (Beckman Coulter, Mississauga, Canada) containing a 600-bp sequencing standard (Beckman Coulter) and then subjected to fragment analysis on a CEQ8800 genetic analysis system (Beckman Coulter). To reduce the manual labor and potential for human error associated with extensive pipetting, a Biomek NX Span-8 automation workstation (Beckman Coulter) was programmed to set up the initial PCRs and dilute PCR products for fragment analysis.
To validate the method, a blinded set of 99 DNA samples was provided by the Public Health Research Institute (NJ). Strain identities and MIRU-VNTR patterns were unblinded only after complete 12-digit patterns were generated for all 99 DNA samples. Concordance between PHL and Public Health Research Institute results was 100%.
To evaluate the utility of MIRU-VNTR in Ontario, typing was performed on 1,308 clinical samples from the PHL strain collection for which IS6110 RFLP profiles were also available. Strains were identified as MTBC by using DNA probes (AccuProbe; Gen-Probe, San Diego, CA) and were originally isolated during 1999 to 2001. Strains identified as Mycobacterium bovis or M. bovis BCG and samples containing multiple Mycobacterium species were excluded from analysis. For cases with multiple cultures, only the first isolate was used. Genomic DNA was extracted according to standard protocols (17) in a dedicated biosafety containment facility.
MIRU-VNTR and IS6110 RFLP data were analyzed with BioNumerics 5.0 (Applied Maths, St-Martin Latem, Belgium). RFLP patterns were compared using band-based Dice statistics with 1% position tolerance such that clustered strains exhibited bands of identical number and position. Strains clustered by MIRU-VNTR were identical at all 12 loci. Analysis by MIRU-VNTR plus IS6110 RFLP employed the unweightedpair group method with arithmetic mean. MTBC lineages were assigned by comparison to the MIRU-VNTR reference strain database (1).
Independently, both methods revealed a large number of unique profiles and some clustered isolates (Table 1) . Maximum strain resolution was achieved when both methods were combined. In general, RFLP was superior for multiband IS6110 strains, whereas resolution of single-band IS6110 isolates required MIRU-VNTR. Initial typing at 12 MIRU-VNTR loci generated two large "pseudoclusters." One contained East Asian lineage strains (pattern 223325173533; n ϭ 110), which are known to be poorly resolved by these 12 loci (12, 16). The second was comprised of strains from the IndoOceanic lineage (pattern 254326223432; n ϭ 80). This group was typed at 12 additional loci (15) . Even though four of the new loci were invariant, extended typing generated 47 new patterns (Fig. 1) . Thirty-five Indo-Oceanic strains had unique profiles, whereas the remaining isolates formed 12 MIRU-VNTR-defined clusters (6 clusters with 2 isolates in each cluster, 3 with 3 each, 1 with 4, and 2 with 10 each). However, 11 of these could be resolved further by RFLP.
Previous genotyping studies have suggested that there is extensive local transmission of TB in Canada. A single MTBC strain is responsible for ϳ25% of all cases in the province of Manitoba (2, 3) . In Quebec, a pyrazinamide-resistant strain and its drug-sensitive ancestor are endemic (10) . In contrast, 84.7% (1,108/1,308) of strains in the present study displayed unique genotypes. The remaining 200 strains formed 77 clusters (Fig. 2) . The largest cluster, 12 strains associated with an outbreak in a homeless shelter in the urban metropolis of Toronto, accounts for Ͻ1% of all provincial cases (20) . Although identical by MIRU-VNTR, RFLP distinguished two groups within this "Toronto" cluster: nine strains of one pattern and three with an extra IS6110 band.
The genotypic diversity of MTBC strains found in this study is likely due to the ethnic diversity of the provincial population.
Many Ontarians (3.4 million/12.1 million people) are foreignborn (14) . Since 1996, ϳ687,000 immigrants have arrived from the 22 nations identified as high-burden countries by the World Health Organization (13, 19) . Reactivation disease is common among recent immigrants to both the United States and Canada (4, 18) . The proportion of total TB cases (ϳ85%) attributed to foreign-born Ontarians is similar to trends in Minnesota (85.3%) and New York (71.1%) but much higher than levels in other Great Lakes states (e.g., Illinois, 58.9%; Wisconsin, 54.3%; Pennsylvania, 51.4; Ohio, 45.6%; Indiana, 43.0; Michigan, 37.6%) (5, 11) .
This study, the first to evaluate the utility of MIRU-VNTR in Ontario, Canada, indicates that the method is an effective first-line genotyping tool. However, the 12-loci strategy can generate pseudoclusters. Resolution of some strains, especially those from the East Asian and Indo-Oceanic lineages, require second-line testing with IS6110 RFLP, additional loci, or spoligotyping. Genotyping revealed MTBC isolates from diverse global lineages, which is consistent with the multicultural origins of Ontario's population. Despite the predominance of reactivation disease, 77 clusters, comprising 200 isolates, were identified. Rapid detection of such clusters, especially those involving unrelated individuals, is essential for effective TB control. Due to its speed and high throughput, MIRU-VNTR will be an important component of the universal, real-time genotyping strategy in Ontario, Canada.
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